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Purpose: The incidence of colorectal cancer in Korea has recently increased, making it the second most common cancer 
in men and the third most common cancer in women. Risk factors for colorectal cancer have been studied worldwide, but 
risk factors specific for the Korean population have not been established. In this study, we investigated incidence trends 
and risk factors of colorectal cancer in Korea.
Methods: A total of 8,846,749 subjects were included. Colorectal cancer incidence was investigated using Korea National 
Health Insurance Service claim data from 2004 to 2014. Colorectal cancer diagnoses were obtained by evaluating colorec-
tal cancer diagnostic codes and the cancer registry for cost sharing. Risk factor identification for colorectal cancer was ob-
tained from National Health Examination data from 2004 to 2005. Cox proportional hazard model statistical analysis was 
used to determine risk factors of colorectal cancer.
Results: The incidence of colorectal cancer gradually increased from 2006 to 2014 (from 45.4/100,000 to 54.5/100,000). 
There was a predominance among men (1.47:1), but incidence trends were similar in both sexes. Old age, high body mass 
index, and no history of colonoscopy were identified as risk factors in both sexes. High fasting blood glucose, familial his-
tory of cancer, frequent alcohol intake, and current smoker were identified as risk factors, especially in men. 
Conclusion: The incidence of colorectal cancer has been increasing in Korea. Colonoscopy screening was a protective fac-
tor for colorectal cancer, and active use of colonoscopy may reduce incidence. Early diagnosis and care are important, 
particularly for the high-risk group.
Keywords: Colorectal neoplasms; Incidence; Risk factors; Population Characteristics
INTRODUCTION
Colorectal cancer is the third most common malignancy world-
wide and, after skin cancer, the second most common malignancy 
in most western countries [1, 2]. In the United States, there are 
141,220 new cases and 49,380 deaths annually due to colorectal 
cancer [3]. The incidence has recently increased in some Asian 
countries, including Korea. Colorectal cancer has become the sec-
ond leading cancer in men and the third most frequent cancer in 
women in Korea [4]. 
Because of the high and increasing incidence, research has been 
conducted on colorectal cancer risk factors. Colorectal cancer is 
associated with dietary factors. Red meat and processed meat di-
ets are known to increase the incidence of colorectal cancer, and 
dietary fiber intake reduces the risk of colorectal cancer [5]. 
Smoking is also associated with risk of colorectal cancer [6]. Med-
ical conditions including obesity and diabetes are known risk fac-
tors of colorectal cancer [7]. Most studies on colorectal cancer risk 
factors have been performed in the United States and Europe, and 
risk factors for colorectal cancer may not be the same in Korea 
because of differences in race, region, and economic level. Azeem 
et al. [8] reported that spicy foods and tapioca increase colorectal 
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cancer in the Asian population. In India, studies have shown that 
spicy foods, low-calorie meals, and alcohol consumption may in-
crease the incidence and severity of colorectal cancer [9]. 
The fecal occult blood test (FOBT) is widely used to screen for 
colorectal cancer. FOBT use is associated with reduced colorectal 
cancer mortality [10]. However, the FOBT has relatively low spec-
ificity and sensitivity for colorectal neoplasms and cancer [11]. In 
addition, the positive predictive value of FOBT is relatively low 
(3%–10%) [12]. Colonoscopy screening during health examina-
tion reduces both the incidence and mortality of colorectal cancer 
[13]. Distal colon flexible sigmoidoscopy also reduces the mortal-
ity of colorectal cancer [14]. Colonoscopy can be performed in 
conjunction with polypectomy, which is also associated with re-
duced mortality [15]. However, due to economic reasons and 
bowel preparation difficulties, routine colonoscopy is difficult to 
execute as a mass screening tool [16].
The general risk factors of colorectal cancer have been studied 
worldwide, but specific risk factors for the Korean population 
have not been researched. In this study, we investigate incidence 
trends and risk factors of colorectal cancer in Korea.
METHODS
Database
The universal health insurance system for all citizens in Korea be-
gan in 1977, and the universal health care system was introduced 
in 1989. Everyone born in Korea is given a unique social security 
number, and almost all medical records are also registered in the 
National Health Insurance Service (NHIS) system. Data regis-
tered in the NHIS system include patient sociodemographic in-
formation, detailed billing details, prescription drug type and 
dosage, hospital information, and information obtained from pe-
riodic inspections during health examination. The inspections 
consist mainly of questions about lifestyle and results of basic di-
agnostic tests. All diseases are coded according to the Korean 
Classification of Disease (KCD), which is similar to the Interna-
tional Classification of Disease, 10th Revision. Many studies have 
been conducted using the KCD. This study was reviewed and ap-
proved by the Institutional Review Board (IRB) of National 
Health Insurance Service Ilsan Hospital (IRB No. 2017-01-021-
001), and a waiver of informed consent was granted for data col-
lection from existing medical records of patients.
Study design and participants
Claims data from the NHIS database from January 1, 2004, to 
December 31, 2014 were used. For a diagnosis of colorectal can-
cer, 2 criteria had to be fulfilled. First, the person had to have a 
KCD diagnostic code of C18, C19, or C20; second, the person 
had to meet the exception rule for cost sharing (V193). The cost 
sharing code is a disease classification code with high accuracy 
because it requires registration by the national cancer manage-
ment project. To determine colorectal cancer risk factors, a cohort 
dataset was constructed. A total of 21,313,265 people had national 
health screening examinations from January 1, 2004 to December 
31, 2005. Of these, 10,783,876 persons were selected as subjects by 
removing duplicates based on 2004 examiners. Patients with 
newly diagnosed cancer (codes C00-C97 by KCD) from January 
1, 2004 to December 31, 2005 were excluded. Since people with 
Korean Medical Care (medical insurance system for low income 
persons) have no or low income and are susceptible to many dis-
eases, they were excluded from this study. To eliminate measure-
ment and observation errors, subjects with health examination 
data outliers were excluded. These outliers are described in the 
supplement, and the detailed flow chart for analysis is shown in 
Fig. 1. 
Statistical analysis
Data are expressed in the form of frequency (%), and chi-square 
tests were performed to determine statistical significance. Most 
variables were changed to categorical data by setting continuous 
data intervals. The criteria for separating categories were not spe-
cific, but the criteria did not violate data uniformity. Based on 
previous studies, most results were reported according to sex. Cox 
proportional hazard model analysis was used to determine the 
risk factors of colorectal cancer. Results were expressed as hazard 
ratio (HR) and 95% confidence interval (CI). The basic assump-
tion of the Cox model was confirmed by log(-log) curves. First, 
significant variables were identified by univariate analysis. Multi-
Fig. 1. Flow chart of subjects included in analysis of colorectal can-
cer risk factors. *Korean medical care: Special medical insurance 
system for the low-income population.
21,313,285 National Health 
Examination examinees from 
2004 to 2005
10,423, 757 National Health 
Examination examiner from 
2004 to 2005
8,846,749 Finally enrolled 
population
10,529,409 Excluded: 
Duplicate examinees
172,360 Excluded: 
Malignancy development (2004–2005)
187,759 Excluded: 
Korean medical care*
1,577,008 Excluded: 
Outliers (Supplement)
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variate analysis was performed using the result of univariate anal-
ysis and correcting for necessary variables. Statistical analysis was 
performed using SAS ver. 9.4 (SAS Institute Inc., Cary, NC, USA). 
P-value <0.05 was considered statistically significant.
RESULTS
To estimate the incidence of colorectal cancer among Koreans, 
the number of newly diagnosed colon cancer cases was counted 
every year from 2006 to 2014, and the incidence and prevalence 
per 100,000 people was calculated. Because of differences in inci-
dence, occurrence and incidence data were presented according 
to age and sex. Overall, there is a pattern of increasing incidence 
until 2012. The incidence per 100,000 people in 2006 was 
45.4/100,000, and this incidence increased to 54.4/100,000 in 
2014. A similar pattern was observed when incidence was ana-
lyzed by sex (Table 1).
Men had higher colorectal cancer incidence than women. The 
peak incidence occurred in 2012 in both sexes, with incidence of 
67.9/100,000 in men and 45.3/100,000 in women (Table 1). In 
2008, the male age group with highest incidence was the 70- to 
79-year-old age group (372.7/100,000); after 2009 this changed to 
the over 80-year-old age group (401.7/100,000). In those under 
40-year-old age, incidence was 2.9/100,000 in 2006 and 3.2/ 
100,000 in 2014. In those aged 40–49, incidence was 31.7/100,000 
in 2006 and 29.1/100,000 in 2014, reflecting a fairly high inci-
dence of colorectal cancer in people below 50-year-old age. In 
2014, the incidence was 212.0/100,000 for men in their 60s, 
347.4/1000,000 for men in their 70s, and 412.2/100,000 for men 
in the over 80-year-old age group. These data indicate a high inci-
dence of colorectal cancer in men over 60-year-old age. In 
women, the highest incidence was observed in women in their 
70s in 2007 (183.2/100,000) and in those over 80-year-old age be-
ginning in 2008 (189.0/100,000). In the group under 40-year-old 
age, incidence was 2.7/100,000 in 2006 and 2.9/100,000 in 2014. 
In women in their 40s, incidence was 26.0/100,000 in 2006 and 
23.0/100,000 in 2014, also reflecting a high incidence of colorectal 
cancer in women below 50-year-old age. In 2014, the incidence 
was 101.9/100,000 for women in their 60s, 181.3/1000,000 for 
women in their 70s, and 220.9/100,000 for women in the over 
80-year-old age group, indicating high incidence in these age 
groups similar to men. In both sexes, incidence in the 70- to 
79-year-old age groups showed a decreasing trend, while inci-
dence in over 80-year-old age groups showed substantial in-
creases. 
Risk factors for colorectal cancer were analyzed by sex. First, the 
results in men are as follows. Risk of colorectal cancer increased 
with age, and HR was highest in the over 80-year-old age group 
(HR, 19.190; P < 0.001). Increased age was a risk factor for 
colorectal cancer in men (Table 2). Risk of colorectal cancer in-
creased with increasing BMI, and BMI over 23 kg/m2 was re-
vealed to be a risk factor of colorectal cancer (23–25 kg/m2: HR, 
1.111; P = 0.0272; ≥25 kg/m2: HR, 1.254; P < 0.001). The risk of 
colorectal cancer was higher when fasting blood glucose was 
higher than 126 mg/dL (HR, 1.217; P < 0.001). The risk of total 
cholesterol level was analyzed among 3 groups of less than 200 
mg/dL, 200–240 mg/dL, and more than 240 mg/dL. There were 
no significant relationships among the 3 groups and risk of 
colorectal cancer. Family history of diabetes mellitus (DM) and 
malignancy was also analyzed. Family history of DM showed no 
significant association with risk of colorectal cancer, but family 
history of malignancy showed increased risk of colorectal cancer 
(HR, 1.163; P < 0.001). Alcohol consumption was analyzed based 
on 5 groups: none, 2–3 times a month, 1–2 times a week, 3–4 
times a week, and almost every day. The results showed that risk 
increased with more frequent alcohol consumption. Smoking sta-
tus was analyzed by non-smoker, ex-smoker, and current smoker. 
Current smokers showed significantly higher risk of colorectal 
cancer than non-smokers and ex-smokers (HR, 1.093; P = 0.021). 
Colonoscopy during health examinations reduced the risk of 
Table 1. Prevalence and incidence of colorectal cancer
Year Overall Men Women
2005 39,000 (79.3)/- 22,752 (92.1)/- 16,248 (66.5)/-
2006 67,336 (136.8)/22,332 (45.4) 39,114 (158.1)/13,038 (52.7) 28,222 (115.2)/9,294 (37.9)
2007 85,816 (172.8)/22,225 (44.7) 49,979 (200.4)/13,086 (52.5) 35,837 (144.9)/9,139 (37.0)
2008 103,112 (206.2)/22,980 (46.0) 60,308 (240.2)/13,674 (54.5) 42,804 (171.9)/9,306 (37.4)
2009 121,765 (242.1)/25,200 (50.1) 71,537 (283.4)/15,132 (59.9) 50,228 (200.5)/10,068 (40.2)
2010 140,895 (278.6)/26,421 (52.2) 83,138 (327.6)/15,836 (62.4) 57,757 (229.2)/10,585 (42.0)
2011 160,642 (315.5)/28,326 (55.6) 95,250 (373.0)/17,165 (67.2) 65,392 (257.7)/11,161 (44.0)
2012 180,708 (353.2)/28,973 (56.6) 107,349 (418.6)/17,413 (67.9) 73,359 (287.4)/11,560 (45.3)
2013 199,693 (388.1)/28,628 (55.6) 118,769 (460.7)/17,226 (66.8) 80,924 (315.3)/11,402 (44.4)
2014 217,955 (421.1)/28,161 (54.4) 129,636 (499.9)/16,804 (64.8) 88,319 (342.0)/11,357 (44.0)
Values are presented as prevalence (per 100,000)/incidence (per 100,000).
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Table 2. Incidence and risk factors of colorectal cancer in men (n=5,105,889)
Variable Total
Colorectal cancer
HR (95% CI) P-value
Yes No
Age (yr)
   <40 1,718,961 (33.7) 4,024 (6.2) 1,714,937 (34.0) 1.000
   40–49 1,550,303 (30.4) 12,122 (18.5) 1,538,181 (30.5) 2.685 (2.331–3.093) <0.001
   50–59 979,572 (19.2) 19,435 (29.7) 960,137 (19.0) 6.529 (5.689–7.492) <0.001
   60–69 608,683 (11.9) 20,637 (31.6) 588,046 (11.7) 13.376 (11.636–15.377) <0.001
   70–79 216,795 (4.2) 8,314 (12.7) 208,481 (4.1) 19.177 (16.334–22.513) <0.001
   ≥80 31,575 (0.6) 817 (1.3) 30,758 (0.6) 19.190 (13.288–27.712) <0.001
Body mass index (kg/m2)
   <18.5 107,303 (2.1) 1,385 (2.1) 105,918 (2.1) 1.000
   18.5–23 1,628,404 (31.9) 19,892 (30.4) 1,608,512 (31.9) 1.071 (0.981–1.170) 0.125
   23–25 1,428,447 (28) 18,725 (28.7) 1,409,722 (28) 1.111 (1.012–1.220) 0.027
   >25 1,941,735 (38) 25,347 (38.8) 1,916,388 (38) 1.254 (1.141–1.377) <0.001
Fasting blood glucose (mg/dL)
   <126 4,759,751 (93.2) 58,073 (88.9) 4,701,678 (93.3) 1.000
   ≥126 346,138 (6.8) 7,276 (11.1) 338,862 (6.7) 1.217 (1.092–1.356) <0.001
Total cholesterol (mg/dL)
   <200 3,038,715 (59.5) 37,931 (58.0) 3,000,784 (59.5) 1.000
   200–240 1,527,822 (29.9) 20,101 (30.8) 1,507,721 (29.9) 0.956 (0.891–1.025) 0.201
   >240 539,352 (10.6) 7,317 (11.2) 532,035 (10.6) 1.018 (0.920–1.126) 0.734
Family history of DM
   No 4,371,505 (92.8) 56,628 (94.4) 4,314,877 (92.8) 1.000
   Yes 338,772 (7.2) 3,378 (5.6) 335,394 (7.2) 0.910 (0.794–1.042) 0.173
Family history of malignancy
   No 4,155,911 (87.9) 53,136 (88.2) 4,102,775 (87.9) 1.000
   Yes 569,367 (12.1) 7,099 (11.8) 562,268 (12.1) 1.163 (1.066–1.269) <0.001
Alcohol consumption
   Never 1,694,201 (33.2) 23,087 (35.8) 1,671,114 (33.6) 1.000
   2–3 times/mo 1,099,887 (21.5) 10,481 (16.3) 1,089,406 (21.9) 1.105 (1.007–1.212) 0.035
   1–2 times/wk 159,186 (3.1) 16,022 (24.8) 1,431,649 (28.8) 1.217 (1.118–1.325) <0.001
   3–4 times/wk 538,531 (10.5) 8,412 (13.0) 530,119 (10.7) 1.360 (1.223–1.511) <0.001
   Everyday 258,287 (5.1) 6,474 (10.0) 251,813 (5.1) 1.490 (1.320–1.682) <0.001
Smoking
   None 2,072,613 (40.6) 29,168 (45.4) 2,043,445 (41.2) 1.000
   Ex-smoker 823,774 (16.1) 11,488 (17.9) 812,286 (16.4) 1.079 (0.994–1.173) 0.070
   Current smoker 2,129,870 (41.7) 23,637 (36.8) 2,106,233 (42.4) 1.093 (1.013–1.180) 0.022
History of colonoscopy
   No 194,655 (39.2) 2,169 (47.9) 192,486 (39.1) 1.000
   Yes 301,849 (60.8) 2,362 (52.1) 299,487 (60.9) 0.501 (0.470–0.533) <0.001
Values are presented as number (%) unless otherwise indicated.
HR, hazard ratio; CI, confidence interval; DM, diabetes mellitus.
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Table 3. Incidence and risk factors of colorectal cancer in women (n=3,654,706)
Variable Total 
Colorectal cancer
HR (95% CI) P-value
Yes No
Age (yr)
   <40 565,986 (15.5) 1,743 (4.7) 564,243 (15.6) 1.000
   40–49 1,192,095 (32.6) 7,619 (20.4) 1,184,476 (32.7) 2.011 (1.624–2.490) <0.001
   50–59 925,748 (25.3) 10,032 (26.8) 915,716 (25.3) 2.987 (2.407–3.707) <0.001
   60–69 657,412 (18.0) 11,496 (30.7) 645,916 (17.9) 5.207 (4.184–6.479) <0.001
   70–79 273,253 (7.5) 5,831 (15.6) 267,422 (7.4) 8.186 (6.452–10.386) <0.001
   ≥80 40,212 (1.1) 669 (1.8) 39,543 (1.1) 9.72 (5.929–15.934) <0.001
Body mass index (kg/m2)
   <18.5 127,463 (3.5) 842 (2.3) 126,621 (3.5) 1.000
   18.5–23 1,519,420 (41.6) 12,711 (34.0) 1,506,709 (41.7) 1.110 (0.975–1.265) 0.116
   23–25 892,897 (24.4) 9,479 (25.4) 883,418 (24.4) 1.221 (1.073–1.388) 0.002
   >25 1,114,926 (30.5) 14,358 (38.4) 1,100,568 (30.4) 1.250 (1.103–1.417) 0.001
Fasting blood glucose (mg/dL)
   <126 347,2851 (95.0) 34,541 (92.4) 3,438,310 (95.1) 1.000
   ≥126 181,855 (5.0) 2,849 (7.6) 179,006 (4.9) 1.183 (0.997–1.404) 0.054
Total cholesterol (mg/dL)
   <200 2,093,347 (57.3) 18,267 (48.9) 2,075,080 (57.4) 1.000
   200–240 1,091,988 (29.9) 12,699 (34.0) 1,079,289 (29.8) 1.067 (0.974–1.170) 0.165
   >240 469,371 (12.8) 6,424 (17.2) 462,947 (12.8) 1.059 (0.939–1.195) 0.346
Family history of DM
   No 3,113,793 (92.2) 32,115 (93.1) 3,081,678 (92.2) 1.000
   Yes 262,790 (7.8) 2,390 (6.9) 260,400 (7.8) 1.115 (0.961–1.294) 0.152
Family history of malignancy
   No 2,921,230 (86.2) 29,605 (85.4) 2,891,625 (86.2) 1.000
   Yes 469,388 (13.8) 5,069 (14.6) 464,319 (13.8) 1.103 (0.990–1.230) 0.076
Alcohol consumption
   Never 2,839,365 (77.7) 30,648 (83.8) 2,808,717 (79.2) 1.000
   2–3 times/mo 457,398 (12.5) 3,513 (9.6) 453,885 (12.8) 0.973 (0.844–1.122) 0.705
   1–2 times/wk 222,337 (6.1) 1,752 (4.8) 220,585 (6.2) 0.925 (0.758–1.129) 0.443
   3–4 times/wk 39,489 (1.1) 387 (1.1) 39,102 (1.1) 1.111 (0.740–1.668) 0.612
   Everyday 22,483 (0.6) 269 (0.7) 22,214 (0.6) 1.494 (0.959–2.327) 0.076
Smoking
   None 3,419,049 (93.6) 34,777 (95.9) 3,384,272 (96.4) 1.000
   Ex-smoker 39,908 (1.1) 434 (1.2) 39,474 (1.1) 1.293 (0.919–1.821) 0.140
   Current smoker 88,959 (2.4) 1,057 (2.9) 87,902 (2.5) 0.988 (0.743–1.313) 0.934
History of colonoscopy
   No 117,231 (34.4) 1,097 (41.4) 116,134 (34.3) 1.000
   Yes 223,914 (65.6) 1,555 (58.6) 222,359 (65.7) 0.609 (0.560–0.663) <0.001
Values are presented as number (%) unless otherwise indicated.
HR, hazard ratio; CI, confidence interval; DM, diabetes mellitus.
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colorectal cancer (HR, 0.501; P < 0.001) (Table 2). 
In women, risk increased with age, and the risk was highest in 
patients over 80 years (HR, 9.720; P < 0.001) (Table 3). Risk in-
creased with increasing BMI, and BMI over 23 kg/m2 was re-
vealed as a risk factor of colorectal cancer (23–25 kg/m2: HR, 
1.221; P = 0.0024; ≥25 kg/m2: HR, 1.250; P = 0.0005). The level of 
fasting blood glucose and total cholesterol were not significant 
risk factors for colorectal cancer. DM and malignancy showed no 
significant relationship with increased colorectal cancer risk in 
women. Frequency of alcohol consumption and smoking were 
not found to be risk factors in women. Colonoscopy also reduced 
the risk of colorectal cancer in women (HR, 0.609; P < 0.001) (Ta-
ble 3).
Risk factors were also analyzed according to location of colorec-
tal cancer. In men, right colon cancer had the greatest increase in 
risk with increasing age, and rectal cancer had the lowest increase 
(Table 4). Frequent alcohol consumption was a risk factor, but was 
not a risk factor in left colon cancer (Table 4). In women, total 
cholesterol level was not a risk factor of colorectal cancer overall, 
but was a risk factor in left colon cancer (Table 5).
DISCUSSION
This study showed a trend of increasing colorectal cancer in Ko-
rea. The incidence has increased from 45.4/100,000 in 2012 to 
54.4/100,000 in 2014. Analysis of old Korean data shows that inci-
dence in men was 1999 in 27.0/100,000, which increased to 50.2 
in 2009. In women, the incidence in 1999 was 17.2/100,000, 
which increased to 26.9/100,000 in 2009 [17]. In our data, the in-
cidence in 2014 was 64.8/100,000 in men and 44.0/100,000 in 
women. This demonstrates that the incidence of colorectal cancer 
in Korea has been dramatically increasing. Compared to other 
countries, the incidence of colorectal cancer in Korea is high. In 
2012, the incidence in men was highest in Korea (50.0/100,000), 
followed by New Zealand (49.1/100,000). Korea had the third 
highest total incidence including men and women the world (Ko-
reans, 37.3/100,000) after New Zealand (43.5/100,000) and the 
Netherlands (38.9/100,000) [17]. The United States used to have 
the highest incidence in the world, but it has been decreasing 
since the 1990s [18]. Compared to Singapore, the incidence is 
very high in Korea. The age-standardized rate in 2008–2012 was 
20.5/100,000 in Singapore [19]. Meat consumption per person in 
Korea was 41.0 kg in 2006 and 51.9 kg in 2014 [20]. The increase 
of meat consumption may be related to the increased incidence of 
colorectal cancer. The incidence of colorectal cancer in Korea has 
been increasing dramatically, with a plateau in incidence since 
2012. The cause of the plateau is unknown, but may be due to the 
increased interest in health care, healthy lifestyle, and eating hab-
its. Since 2009, colonoscopy has been performed for those who 
are FOBT positive through National Health Examinations. An in-
crease in health examinations and colonoscopies may have slowed 
down the increasing trend. Additional research is needed to find 
the exact cause.
Unlike other malignancies, the genetic and molecular biological 
pathogenesis of colorectal cancer has been extensively studied. 
Transition from adenoma to carcinoma describes the natural his-
tory of colon cancer development. In addition, the development 
of colorectal cancer due to microorganisms and intestinal factors 
also has been well-studied [21]. The functions of the large intes-
tine are to deliver food from the small intestine to the rectum and 
to absorb water and electrolytes. Intestinal microorganisms me-
tabolize the remaining food and digestive fluids. Cells in the colon 
crypts are active and proliferative, requiring nutrients. The prolif-
erative process is affected by dietary changes [22]. Genetic 
changes that develop during dietary changes accumulate and lead 
to genomic instability. These changes result in colorectal cancer 
development [23]. By-products of protein digestion are fermented 
by colonic bacteria to produce ammonia, phenol, and hydrogen 
sulfide. Nitrate and nitrite are introduced into the colonic mucosa 
when processed meat is ingested. These substances cause inflam-
mation and damage to the colon mucosa [24]. 
To ascertain the risk factors of colorectal cancer, variables in-
cluded in the National Health Examination data and reported as 
risk factors in other studies were analyzed. In our study, increased 
age and BMI were revealed as risk factors in both men and 
women. Colonoscopy performance as part of health examina-
tions was a protective factor for colorectal cancer. Especially in 
men, high fasting blood glucose and family history of malignancy 
were risk factors. Frequent alcohol consumption and current 
smoking were also risk factors for colorectal cancer in men. The 
relationship between increased age and colorectal cancer has been 
well-studied [25]. Our data also demonstrated that increased age 
is a risk factor for both sexes. Obesity is also a risk factor for 
colorectal cancer [26, 27]. Shin et al. [28] reported that high BMI 
is a risk factor for colorectal cancer in men, and low BMI is a pro-
tective factor in women. 
The relationship of colorectal cancer with family history has 
been well-studied. Familial history of colorectal cancer increases 
the risk of colorectal cancer [29]. Familial history of other malig-
nancies, such as gastric cancer and prostate cancer, also increases 
the risk of colorectal cancer [30, 31]. In this study, family history 
of DM and any malignancy was investigated, and familial history 
of DM-related malignancy was a risk factor in men. Disease pres-
ence is a risk factor for colorectal cancer. A personal history of 
DM is well known to increase the risk of colorectal cancer [7]. In 
our study, serum cholesterol level was not a significant risk factor 
for colorectal cancer, and high serum glucose level was a risk fac-
tor only in men.
Dietary habits are known to be important risk factors. Ingestion 
of red meat and processed meat such as bacon, ham, or sausage 
are well known risk factors [32]. Eating fried meat increases the 
risk of colorectal cancer [33]. Every 30-g increase of daily red 
meat and processed meat consumption increases colorectal can-
cer risk by 10% [34]. Increased total meat intake increases the risk 
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of colorectal cancer by 21%–28% [35]. An experimental study re-
vealed that the fatty acids of animal fat act as a carcinogen in 
colorectal cancer [36]. Consumption of dietary fiber is a known 
protective factor for colorectal cancer [37]. As dietary fiber fer-
ments in the large intestine, short chain fatty acids (SCFA), such 
as butyrate, acetate, and propionate, are produced. SCFA are used 
as a main energy source for colonic mucosa cells to maintain anti-
inflammatory functions, preventing development of colorectal 
cancer [38]. Dietary risks are difficult to research because of diffi-
culties in acquiring detailed data. In this study, acquisition of such 
data was impossible. The National Health Examination data ques-
tionnaire only differentiates among meat-eaters, eaters of both 
Table 4. Risk factors of colorectal cancer by location in men
Variable All Colon Rectum Right colon Left colon
Age (yr)
   <40 1.000 1.000 1.000 1.000 1.000
   40–49 2.685 (2.331–3.093)* 3.187 (2.642–3.844)* 2.113 (1.699–2.629)* 3.673 (2.491–5.417)* 3.128 (1.896–5.163)*
   50–59 6.529 (5.689–7.492)* 7.935 (6.611–9.524)* 4.935 (3.987–6.109)* 9.66 (6.623–14.089)* 7.164 (4.385–11.703)*
   60–69 13.376 (11.636–15.377)* 17.217 (14.327–20.690)* 8.889 (7.131–11.081)* 20.668 (14.122–30.248)* 17.226 (10.548–28.132)*
   70–79 19.177 (16.334–22.513)* 24.490 (19.917–30.113)* 13.119 (10.074–17.085)* 32.97 (21.622–50.274)* 31.258 (18.306–53.374)*
   ≥80 19.190 (13.288–27.712)* 24.431 (15.624–38.203)* 13.263 (6.889–25.534)* 30.096 (12.431–72.866)* 23.129 (6.759–79.152)*
Fasting blood glucose (mg/dL)
   <126 1.000 1.000 1.000 1.000 1.000
   ≥126 1.217 (1.092–1.356)* 1.231 (1.081–1.401)* 1.191 (0.977–1.452) 1.207 (0.927–1.572) 1.512 (1.1–2.078)*
Total cholesterol (mg/dL)
   <200 1.000 1.000 1.000 1.000 1.000
   200–240 0.956 (0.891–1.025) 0.970 (0.893–1.055) 0.923 (0.814–1.046) 1.124 (0.952–1.327) 1.039 (0.833–1.296)
   >240 1.018 (0.92–1.126) 0.973 (0.859–1.102) 1.117 (0.939–1.329) 1.041 (0.810–1.337) 1.114 (0.810–1.533)
Family history of DM
   No 1.000 1.000 1.000 1.000 1.000
   Yes 0.910 (0.794–1.042) 0.821 (0.691–0.975)* 1.103 (0.884–1.376) 0.584 (0.388–0.881)* 0.953 (0.622–1.458)
Family history of malignancy
   No 1.000 1.000 1.000 1.000 1.000
   Yes 1.163 (1.066–1.269)* 1.128 (1.014–1.254)* 1.243 (1.068–1.447)* 0.989 (0.787–1.243) 1.380 (1.058–1.801)*
Alcohol consumption
   Never 1.000 1.000 1.000 1.000 1.000
   2–3 times/mo 1.105 (1.007–1.212)* 1.024 (0.914–1.146) 1.305 (1.109–1.536)* 1.220 (0.968–1.537) 0.975 (0.732–1.298)
   1–2 times/wk 1.217 (1.118–1.325)* 1.153 (1.041–1.277)* 1.380 (1.186–1.607)* 1.475 (1.200–1.813)* 0.838 (0.633–1.110)
   3–4 times/wk 1.360 (1.223–1.511)* 1.262 (1.110–1.435)* 1.607 (1.334–1.936)* 1.344 (1.025–1.763)* 0.947 (0.664–1.352)
   Everyday 1.490 (1.320–1.682)* 1.523 (1.321–1.757)* 1.416 (1.123–1.785)* 2.011 (1.531–2.642)* 1.14 (0.765–1.698)
Smoking
   None 1.000 1.000 1.000 1.000 1.000
   Ex-smoker 1.079 (0.994–1.173) 1.101 (0.997–1.216) 1.033 (0.890–1.200) 1.270 (1.045–1.544)* 1.198 (0.928–1.548)
   Current smoker 1.093 (1.013–1.180)* 1.089 (0.992–1.195) 1.101 (0.963–1.259) 1.091 (0.903–1.318) 1.018 (0.789–1.312)
Experience of colonoscopy
   No 1.000 1.000 1.000 1.000 1.000
   Yes 0.501 (0.470–0.533)* 0.539 (0.500–0.582)* 0.422 (0.377–0.472)* 0.289 (0.247–0.338)* 0.593 (0.484–0.726)*
Values are presented as hazard ratio (95% confidence interval).
HR, hazard ratio; CI, confidence interval; DM, diabetes mellitus.
*P < 0.05.
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meat and vegetables, and vegetarians. Increased consumption of 
alcohol is also a risk factor for colorectal cancer. One report con-
cluded that that consumption of more than 45 g/day of ethanol 
increases risk of colorectal cancer by 41% [39]. Our data only as-
sessed frequency of alcohol consumption; in the future, the kind 
and amount of alcohol consumption should be included for more 
detailed analyses. 
Many tools have been developed for colorectal screening. These 
screening tools decrease colorectal cancer death through early 
identification and removal of polyps [40]. Colonoscopy is widely 
used to screen for colorectal cancer in many countries. Colonos-
copy is the gold standard for colorectal cancer screening. Colo-
Table 5. Risk factors of colorectal cancer by location in women
Variable All Colon Rectum Right colon Left colon
Age (yr)
   <40 1.000 1.000 1.000 1.000 1.000
   40–49 2.011 (1.624–2.490)* 1.824 (1.431–2.325)* 2.675 (1.701–4.207)* 2.388 (1.249–4.565)* 5.024 (1.553–16.254)*
   50–59 2.987 (2.407–3.707)* 2.624 (2.052–3.354)* 4.341 (2.756–6.837)* 4.472 (2.341–8.544)* 7.939 (2.462–25.603)*
   60–69 5.207 (4.184–6.479)* 4.565 (3.558–5.856)* 7.642 (4.826–12.101)* 7.252 (3.748–14.032)* 23.470 (7.327–75.178)*
   70–79 8.186 (6.452–10.386)* 7.101 (5.402–9.335)* 12.329 (7.553–20.125)* 13.512 (6.723–27.157)* 41.612 (12.740–135.913)*
   ≥80 9.720 (5.929–15.934)* 6.561 (3.383–12.721)* 20.932 (9.533–45.963)* 20.429 (6.395–65.260)* 30.182 (4.986–182.694)*
Fasting blood glucose (mg/dL)
   <126 1.000 1.000 1.000 1.000 1.000
   ≥126 1.183 (0.997–1.404) 1.187 (0.970–1.452) 1.176 (0.853–1.623) 1.326 (0.843–2.088) 1.062 (0.654–1.724)
Total cholesterol (mg/dL)
   <200 1.000 1.000 1.000 1.000 1.000
   200–240 1.067 (0.974–1.170) 1.051 (0.944–1.171) 1.112 (0.933–1.326) 0.979 (0.754–1.271) 1.320 (1.004–1.735)*
   >240 1.059 (0.939–1.195) 1.043 (0.905–1.202) 1.105 (0.880–1.386) 0.852 (0.597–1.217) 1.614 (1.172–2.223)*
Family history of DM
   No 1.000 1.000 1.000 1.000 1.000
   Yes 1.115 (0.961–1.294) 1.111 (0.934–1.321) 1.128 (0.844–1.507) 1.371 (0.922–2.037) 0.810 (0.479–1.370)
Family history of malignancy
   No 1.000 1.000 1.000 1.000 1.000
   Yes 1.103 (0.990–1.230) 1.140 (1.006–1.292)* 1.001 (0.805–1.245) 0.870 (0.619–1.223) 1.000 (0.715–1.398)
Alcohol consumption
   Never 1.000 1.000 1.000 1.000 1.000
   2–3 times/mo 0.973 (0.844–1.122) 1.036 (0.881–1.219) 0.803 (0.597–1.081) 0.958 (0.633–1.451) 0.726 (0.434–1.216)
   1–2 times/wk 0.925 (0.758–1.129) 0.860 (0.675–1.096) 1.095 (0.771–1.554) 0.860 (0.477–1.552) 0.940 (0.494–1.785)
   3–4 times/wk 1.111 (0.740–1.668) 1.181 (0.739–1.888) 0.945 (0.419–2.132) 1.860 (0.755–4.578) 1.360 (1.122–1.412)
   Everyday 1.494 (0.959–2.327) 1.610 (0.965–2.685) 1.229 (0.506–2.983) 1.230 (0.917–1.650) 2.106 (0.672–6.603)
Smoking
   None 1.000 1.000 1.000 1.000 1.000
   Ex-smoker 1.293 (0.919–1.821) 1.276 (0.856–1.902) 1.345 (0.692–2.613) 0.631 (0.156–2.551) 1.099 (0.350–3.456)
   Current smoker 0.988 (0.743–1.313) 0.762 (0.522–1.112) 1.586 (1.026–2.450)* 1.115 (0.520–2.390) 0.172 (0.024–1.234)
Experience of colonoscopy
   No 1.000 1.000 1.000 1.000 1.000
   Yes 0.609 (0.560–0.663)* 0.712 (0.645–0.787)* 0.406 (0.346–0.475)* 0.312 (0.246–0.397)* 0.673 (0.525–0.865)*
Values are presented as hazard ratio (95% confidence interval).
HR, hazard ratio; CI, confidence interval; DM, diabetes mellitus.
*P < 0.05.
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noscopy has high sensitivity and specificity, and simultaneous 
polypectomy is available during colonoscopy [41]. Even with nor-
mal findings, colonoscopy reduces the risk of colorectal cancer 
[42] and colorectal cancer-related death [43]. However, due to 
economic considerations and difficulties in bowel preparation, 
colonoscopy cannot always be used as a frequent screening tool. 
In many countries, colonoscopy for FOBT-positive individuals is 
widely used for colorectal cancer screening [44]. In our data, his-
tory of colonoscopy was a protective factor against colorectal can-
cer in both sexes. Routine use of colonoscopy reduces the inci-
dence of colorectal cancer. 
In this study, we identified a trend in colorectal cancer incidence 
in Korea over the past 10 years. The incidence substantially in-
creased until 2012. We also analyzed risk factors of colorectal can-
cer in men and women. Because many factors are involved in the 
development of colorectal cancer, not all identified risk factors 
may be primary risk factors. However, this study analyzed risk 
factors for a large population in Korea. The National Health Ex-
amination data on lifestyle and eating habits are limited, and data 
that are more detailed may provide meaningful results about risk 
factors in the future.
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